Brief: Medigene H1 EBITDA Loss Narrows to EUR 4.5 Million
Aug 12 (Reuters) - Medigene AG MDG1k.DE :
* S REVENUES INCREASED BY 17% TO EUR4.3 M IN FIRST HALF OF
2021
(6M 2020: EUR3.7 M)
* H1 EBITDA IMPROVED BY 61% TO EUR-4.5 M (6M 2020: EUR-11.3
M) DUE
TO REALIGNMENT AND ASSOCIATED EFFICIENCY MEASURES.
* CONFIRMS FINANCIAL FORECAST
Source text for Eikon: ID:nPexMCcJya
Further company coverage: MDG1k.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million